Canasa and Spiriva drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Canasa (mesalamine) and Spiriva (tiotropium bromide monohydrate). Common drug interactions include headache among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Canasa and Spiriva. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Canasa?

Canasa has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 1,676 Canasa users. Check the latest studies of Canasa.

What is Spiriva?

Spiriva has active ingredients of tiotropium bromide monohydrate. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 156,666 Spiriva users. Check the latest studies of Spiriva.



On Jul, 04, 2026

39 people who take Canasa and Spiriva together, and have interactions are studied.

Canasa and Spiriva drug interactions.

What are the common drug interactions of Canasa and Spiriva, by gender? *:

female:

  1. Headache (pain in head)
  2. Fatigue (feeling of tiredness)
  3. Cardiac failure congestive
  4. Diarrhoea
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Nightmare (unpleasant dream)
  7. Vascular occlusion (sudden blockage of a blood vessel, usually with a clot)
  8. Somnambulism (sleep walking)
  9. Pneumonia
  10. Drug hypersensitivity

male:

  1. Diarrhoea
  2. Weight decreased
  3. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  4. Fall
  5. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  6. Chronic kidney disease
  7. Dizziness
  8. Presyncope
  9. Psoriasis (immune-mediated disease that affects the skin)
  10. Renal failure (kidney dysfunction)

What are the common drug interactions of Canasa and Spiriva, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Back pain
  2. Headache (pain in head)
  3. Impaired work ability
  4. Surgery

50-59:

  1. Headache (pain in head)
  2. Fatigue (feeling of tiredness)
  3. Diarrhoea
  4. Weight decreased
  5. Fall
  6. Back pain
  7. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  8. Abnormal dreams
  9. Dizziness
  10. Impaired work ability

60+:

  1. Acute respiratory failure
  2. Hypoxia (low oxygen in tissues)
  3. Somnambulism (sleep walking)
  4. Vascular occlusion (sudden blockage of a blood vessel, usually with a clot)
  5. Abdominal pain
  6. Abdominal rigidity
  7. Blood pressure systolic increased
  8. Cataplexy (loss of muscle tone accompanied by full conscious awareness)
  9. Chronic kidney disease
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 21 people, 53.85%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 20 people, 51.28%
  3. High Blood Pressure: 6 people, 15.38%
  4. High Blood Cholesterol: 4 people, 10.26%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 10.26%
  6. Asthma: 4 people, 10.26%
  7. Hypokalemia (low potassium): 3 people, 7.69%
  8. Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 7.69%
  9. Psoriasis (immune-mediated disease that affects the skin): 3 people, 7.69%
  10. Hiv Infection: 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Canasa and Spiriva?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Canasa and Spiriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Canasa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Spiriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Canasa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Spiriva and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on mesalamine and tiotropium bromide monohydrate (the active ingredients of Canasa and Spiriva, respectively), and Canasa and Spiriva (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: